Maine

Increasing Blood Lead Testing Among MaineCare Recipients in Maine

Maine law says every child must be tested for lead, yet Medicaid enrolled children — the most at risk — are slipping through the cracks. This gap leaves some of Maine's children at risk of undetected lead poisoning, delaying the interventions and support services.

The Maine CDC Childhood Lead Poisoning Prevention Program (MCLPPP) launched a targeted initiative in October 2023, which involved leveraging funding from the Centers for Medicare and Medicaid Services to distribute LeadCare II point-of-care analyzers to 22 medical practices across the state. Practices were selected based on low testing rates and high proportions of MaineCare patients, with the potential to reach over 1,400 MaineCare-covered 1- and 2-year-olds — the age group most critical for early lead poisoning detection. Enrolled practices also received lead education, results reporting support, and guidance on integrating testing into clinical workflows.

The initiative has done more than put analyzers in clinics — it has built lasting public health infrastructure. MCLPPP forged strong partnerships with providers and clinical staff across 8 of Maine's 16 counties, facilitating regular data reviews, identifying barriers to testing, and fostering a culture of shared best practices among all participating practices. With ongoing quarterly data reviews and workflow analyses planned through the coming year, the first full year of data will be available in spring 2026, poised to demonstrate the real-world impact of this collaborative approach to childhood lead poisoning prevention.